Gold­en Tri­an­gle gets £75M in fresh ven­ture funds for Cam­bridge U spin­outs

To­day’s edi­tion of End­points in­cludes a new start­up in a boom­ing Kendall Square and a $1 bil­lion-plus biotech cam­pus for South San Fran­cis­co. So let’s wind up with some up­beat news for that oth­er Cam­bridge biotech clus­ter — in the UK.

Cam­bridge In­no­va­tion Cap­i­tal, which is charged with fund­ing spin­outs from the fa­mous­ly sto­ried uni­ver­si­ty, has raised £75 mil­lion, or close to $100 mil­lion af­ter you put it through a post-Brex­it con­ver­sion. That’s more than twice what the CIC group has in­vest­ed so far, and biotech will be a key fo­cus.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.